Bham Pharm is a global medical communications agency that provides medical writing and regulatory documentation services for pharmaceutical, biotech, and medical device companies, managing communication documents throughout the lifecycle of new drugs and treatments.

Bham Pharm

Bham Pharma | 2,793 followers on LinkedIn. Your full-service medical writing and communications consultancy! | Are you a pharmaceutical company or researcher in need of expert medical writing services? 🌐💊

Do you feel overwhelmed by the complex task of creating accurate and compelling scientific content? 🤯📚

Are you struggling with time constraints and the demand for high-quality written materials?

I am a registered Diverse Supplier helping biotech, pharma, and medical devices companies bring their products to market and patients through…

Bilal Bham

UK Sales Manager

John Donegan

Bham Pharma

Our CEO Bilal Bham is living with Grave's Disease and Thyroid Eye Disease (TED). As a patient and pharma/biotech professional, he wants to help patients, and biotechs researching the space, with his knowledge and experiences 🧪 argenx is one of those biotechs researching TED. Shelley Gerson , their head of patient advocacy, kindly invited Bilal to their offices in Ghent, Belgium, and interviewed him in front of an audience of #argenx colleagues about his life experiences as a patient, and how he saw the research space evolving as a pharma professional 💬 We thank #argenx colleagues for their kindness, time, and generosity in making this possible, and for endeavouring to help patients like Bilal for whom surgery is currently the only approved option (in the UK via the NHS ) 🙌🏾 #patientadvocacy #gravesdisease #thyroideyedisease #autoimmunedisease

Our CEO Bilal Bham is at Disneyland Paris for the WEConnect International Europe Supplier Diversity & Inclusion Conference! If you see him, please do go and chat to him 😊 #Diversity #Equity #Inclusion #SupplierDiversity #WeConnectInternational

Did you know that we are a registered diverse supplier? Our CEO Bilal Bham is in London over the next 2 days attending the MSDUK ESDP Business Diversity Conference, learning, and connecting with professionals from pharma and other industries, and fellow business owners! If you see him, do go say hi to him 🙌🏾

Real-world evidence (RWE) is transforming regulatory medical writing. For example, the FDA approved a new indication for Pfizer’s Ibrance (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include men with certain types of metastatic breast cancer. In pharmacovigilance, it has become a mainstay to use routinely collected data about a patient’s health status or healthcare delivery from various sources other than traditional clinical trials to support decision-making. Have you seen the use of RWE in regulatory medical writing? If so, comment and let us know! #RegulatoryWriting #RealWorldEvidence #MedicalWriting #BhamPharma

📄 ***We are available for projects!*** 📄 #medicalwriter #medicalwriting #medicalcommunications #medcomms #BhamPharma

Bham Pharma's tips on writing better clinical trial protocols: ✒ To write better clinical trial protocols, focus on clarity, consistency, and compliance. ✒ Clearly define objectives, endpoints, and methodologies. Ensure alignment with regulatory guidelines and ethical standards. ✒ Include detailed instructions for the Investigators and consider patient safety at every step. Regularly review and update protocols based on emerging data and feedback. #BhamPharma #Regulatorymedicalwriting

Patient-reported outcomes (PRO) are reshaping regulatory writing. This approach ensures submissions reflect true patient experiences and treatment impacts. PRO measures have become crucial in evaluating clinical outcomes to assess the success of therapeutic interventions. Regulatory agencies agree that patients are the experts in understanding what it is like to live with their condition and what value can be assigned to their treatment. Recent refinements in data reporting have allowed rigorous interpretation of the results of these types of outcome measures. Careful understanding of PRO data interpretation is pivotal to applying these tools in regulatory decision-making. #BhamPharma #MedicalWriting

Thyroid Eye Disease (TED) is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed causing the eyes to 'bulge'. Learn about it in this comprehensive infographic! #thyroideyedisease #gravesdisease

Are you ready to take your pharma brand to new heights? 🌟 Effective communication is essential for standing out in the competitive market. That's where strategic medical communication comes into play! Here are some key strategies: Targeted Messaging: Develop personalised messages that resonate with specific healthcare professionals, patients, and stakeholders, ensuring relevance and engagement. Thought Leadership Content: Produce high-quality content that establishes the brand as an authoritative voice in its therapeutic area, fostering trust and credibility. Multichannel Approach: Implement a cohesive strategy across various communication channels, including digital platforms, conferences, publications, and key opinion leader (KOL) engagements, to maximise brand exposure. Brand Positioning: Define and reinforce the brand's unique value proposition through consistent messaging and positioning strategies, distinguishing it from competitors. Engagement Strategies: Foster meaningful interactions with stakeholders through interactive workshops, webinars, and educational initiatives, fostering brand loyalty and advocacy. Data-driven Insights: Utilise analytics and market research to gain actionable insights into audience preferences, behaviours, and trends, optimising communication strategies for maximum impact. Collaborative Partnerships: Forge strategic collaborations with KOLs, patient advocacy groups, and industry partners to amplify brand messaging and extend reach within target audiences. Measurable Outcomes: Establish clear objectives and key performance indicators (KPIs) to evaluate the effectiveness of communication efforts, enabling continuous improvement and refinement of strategies for ongoing brand elevation. Ready to elevate your pharma brand with strategic medical communication? Let's connect and explore how we can help you achieve your goals! Contact us at www.bhampharma.com for more information. #PharmaMarketing #MedicalCommunication #BrandElevation

It's no longer sufficient to solely focus on the pill itself. We're entering an era where communication must transcend traditional boundaries, spotlighting the value embedded within pharma solutions. At Bham Pharma, we're not just about selling a service; we're about creating narratives that resonate deeply, driving understanding, trust, and ultimately, action. Our approach goes beyond the pill, spotlighting comprehensive benefits. We probe into the broader impact of pharma solutions, emphasising improved patient outcomes, healthcare efficiencies, and societal advancements. We captivate audiences with advance communication strategies. Through captivating narratives, and engaging visuals, we ensure your message resonates and inspires action, driving meaningful engagement with your brand. Customising messages for global impact, respecting local regulations and cultures. With a deep understanding of international markets, we adapt communication strategies to align with diverse regulatory environments, cultural nuances, and language preferences, ensuring maximum impact and resonance. Empowering healthcare professionals to endorse and prescribe with confidence. We equip HCPs with comprehensive knowledge and resources, enabling them to make informed decisions about your products and confidently advocate for them, ultimately driving uptake and patient adherence. 🤝Let's collaborate to amplify your brand's voice, inspiring audiences to see the bigger picture and embrace the value that lies #BeyondThePill . Together, we'll navigate the evolving healthcare sector, driving meaningful change and improving lives. Contact us at www.bhampharma.com for more information. #PharmaCommunication #MedicalInnovation #ValueBasedCare #HealthcareMessaging

Metric
Company Name	Bham Pharm
Symbol
MSH ID	COM:BHAMPHARMA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Communications
Country	US
Stage
Employee Count
Website	bhampharma.com
LinkedIn	bhampharma
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BHAM

COM:BHAMPHARMA

Bham Pharm

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue